TradingKey

• NZDUSD advanced on hawkish RBNZ policy repricing and higher bond yields. • The U.S. dollar faced headwinds from expected Federal Reserve policy stability. • Technical indicators show neutral MACD and RSI with overbought Williams %R.

• Third-quarter earnings beat expectations, prompting management to raise full-year guidance. • An expanded Amazon partnership positions 3M within data center infrastructure markets. • Analysts maintain buy ratings with an average price target of $183.85.

• Northrop Grumman reported strong third-quarter earnings that beat Wall Street expectations. • Management raised its full-year profit guidance and segment operating income forecasts. • The company achieved a record order backlog driven by persistent global demand.

• General Motors reported third-quarter results that surpassed Wall Street consensus estimates. • Investors reacted negatively because the profit guidance missed analyst expectations. • Technical indicators show mixed signals alongside a moderate level of media coverage.

• Bristol Myers Squibb stock gained momentum ahead of major medical conference presentations. • Analysts upgraded targets following strong clinical pipeline updates and commercial growth assets. • The company reported $48.19B annual revenue and $7.05B net profit.

• Enterprise tokenization adoption and institutional settlement on Ethereum boosted market confidence. • Record staking participation reduced liquid supply and triggered short covering in derivatives. • Technical indicators show a MACD sell signal and a neutral RSI condition.

• XRP experienced a localized recovery driven by opportunistic buying near technical support. • Whale activity showed custodial transfers without immediate sell-side pressure or liquidations. • Technical indicators like the MACD and Williams %R currently suggest sell conditions.

• Capital shifted to Solana ahead of the upcoming Alpenglow consensus upgrade. • Strong technical defense and on-chain metrics reinforced the upward price movement. • Technical indicators show a MACD sell signal and neutral RSI condition.

• GE Aerospace stock fell due to profit-taking despite beating third-quarter expectations. • Rising engine service expenses and durability costs weighed on free cash flow. • Analysts maintain an average price target of $390.96 with Buy ratings.

• Eli Lilly's metabolic drugs and pipeline advancements drove strong investor sentiment. • The company reported $65.18B in annual revenue and $20.64B net profit. • Technical indicators show a buy signal with an RSI of 71.633.

• Lam Research faced volatility due to broader semiconductor sector weakness and AI spending concerns. • Pre-earnings repositioning and high expectations drove tactical selling ahead of quarterly results. • The MACD indicates a sell signal while the Williams %R suggests oversold conditions.

• Zero-day vulnerability disclosures caused selling pressure and intraday volatility. • Elevated valuation multiples prompted analyst downgrades and profit-taking. • Technical indicators show a neutral MACD and oversold Williams %R.

• Merck shares rose due to positive oncology pipeline and Phase 3 trial data. • Strategic portfolio expansion and cardiovascular treatments alleviate patent expiration and revenue concerns. • Analysts maintain buy ratings with an average price target of $154.68.

TradingKey - Tesla (TSLA) is set to report its Q3 2026 financial results after the market close on October 21, Eastern Time. While the company's previously announced third-quarter deliveries exceeded market expectations, against the backdrop of rising capital expenditures and increased investment in AI and autonomous driving, investors need to focus on whether these sales can translate into profits, free cash flow, and more stable gross margins. Meanwhile, after hitting a local high in early October and experiencing a continuous pullback, TSLA's stock price has recently rebounded to around $370, making this earnings report a critical variable in determining whether the stock can retest its previous highs in the short term.

Omnicom’s Credera announced a five-year strategic collaboration agreement with AWS focused on enterprise marketing transformation, infrastructure modernization, and production AI deployment.

The ban on advanced robotics is impacting chip manufacturing, and Intel's stock price could continue to fall toward the $80 mark.

• Strong UK labor market data drove the GBP/USD exchange rate advancement. • UK unemployment dropped to 4.7 percent while wage growth firmed. • Investors scaled back expectations for near-term Bank of England monetary easing.

AmeriServ’s Q3 2026 earnings showed net income rising 21.9% to $3.1 million, while diluted EPS increased to $0.18 from $0.15. Total revenue, calculated as net interest income plus non-interest income, grew about 3.6% to $16.0 million as the net interest margin widened 14 basis points to 3.41%. Lower funding costs, higher securities income, and a $363,000 favorable change in the credit-loss provision offset a 5.9% decline in average loans and higher professional fees, highlighting stronger profitability but continued pressure on loan balances.

GE Aerospace's financial results exceeded expectations, but its stock price remained under downward pressure, testing the $300 level.

Alaska Airlines and Hawaiian Airlines will add year-round nonstop routes from Seattle to Osaka and Papeete, with four weekly Osaka flights beginning May 14, 2027.